DNA homologous recombination anomaly detection method and application thereof
A detection method and homologous recombination technology, applied in the field of medical molecular biology, can solve problems such as genome instability, and achieve the effects of reducing sequencing costs, high capture efficiency, and good capture stability and uniformity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0036] Example 1. Establishment of detection method for abnormal DNA homologous recombination
[0037] 1. Probe design
[0038] (1) SNP screening
[0039] Screen 50,000 SNP sites from 301 Chinese populations including the Beijing Han population (CHB), the Southern Han population (CHS), and the Dai population in Xishuangbanna (CDX) in the Thousand Genomes database according to the following rules (see the table below for some points) 1):
[0040] A. Eliminate Y chromosome and mitochondrial SNPs, and filter SNPs with minor allele frequency (MAF) less than 5%;
[0041] B. Filter SNPs that deviate significantly from the Hardy-Weinberg equilibrium;
[0042] C. Filter Insertion and Deletion;
[0043] D. SNPs that do not contain repeat regions within 75 bp upstream and downstream of the screening site;
[0044] E. Screen for SNPs within 75 bp upstream and downstream of the site that have no homology to other regions of the human genome;
[0045] F. The interval is 30KB, and th...
Embodiment 2
[0104] Embodiment 2, using the method of embodiment 1 to detect the HRD of 11 routine ovarian cancer patients
[0105] Using the method of Example 1, the HRD of 11 patients with ovarian cancer (all with the informed consent of the patients) were detected. The test results show that the reagent and method of Example 1 have a high capture rate for the target region, the average effective sequencing READ amount of the target region reaches 20Mb, and the average sequencing depth of the target region is above 3000X (see Table 2).
[0106] Table 2, utilize the method of the present invention to the quality control data result that 11 routine ovarian cancer patients detect
[0107]
[0108] By analyzing the BRCA gene mutations and HRD characteristic genomic scar events in 11 patients with ovarian cancer, such as loss of heterozygosity (Loss of Heterozygosity), Telomeric Allelic Imbalance, and Large- scale State Transitions), etc., respectively, according to the influence range of...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com